Bassett L W
Iris Cantor Center for Breast Imaging, UCLA Medical Center.
Radiol Clin North Am. 1992 Jan;30(1):93-105.
Because mammographically detected calcifications are frequently the only sign of breast cancer, the breast radiography equipment, screen-film imaging package, and film processing should be optimized to detect such calcifications. For this purpose, dedicated units with molybdenum targets, microfocal spot magnification capability, reciprocating grids, and high output x-ray tubes are required. With the greater use of state-of-the-art mammography, intraductal carcinoma, or DCIS, manifested only by calcifications is being detected more frequently than ever. DCIS can be of the comedo, cribriform, or micropapillary types. Comedocarcinoma, characterized by linear and branching (casting) calcifications, is the most aggressive type, and it has the highest rate of recurrence after breast-conserving surgery. Cribriform and micropapillary calcifications are characteristically punctate and vary in size and shape. In addition to histologic type, the recurrence of DCIS is related to its extent at detection and whether adequate tissue was removed at the time of breast-conserving surgery. Biopsies for suspicious calcifications should be followed immediately by specimen radiography to verify their removal. If breast-conserving surgery is elected for DCIS, the resected segment of tissue should be examined with pathologic techniques designed to determine whether the margins are clear of tumor. For DCIS and invasive cancers with extensive intraductal component, microfocus magnification mammography over the surgical site is recommended prior to radiotherapy to identify any residual tumor calcifications. Although state-of-the-art mammography is very sensitive in the detection of calcifications, it is low in specificity, thus resulting in a large number of false-positive mammograms and a relatively low true-positive biopsy rate. While some benign calcifications cannot be distinguished from those of malignancy, the number of biopsies for benign conditions can be decreased by careful analysis of the mammograms in a search for features indicating benignity.
由于乳腺钼靶检查发现的钙化灶常常是乳腺癌的唯一征象,因此乳腺摄影设备、屏-片成像组件以及胶片处理都应进行优化,以检测出此类钙化灶。为此,需要具备钼靶、微焦点放大功能、往复式滤线栅和高输出X射线管的专用设备。随着先进乳腺钼靶检查的广泛应用,仅表现为钙化灶的导管内癌(DCIS)比以往任何时候都更频繁地被检测出来。DCIS可呈粉刺型、筛状型或微乳头型。粉刺癌以线性和分支状(铸型)钙化灶为特征,是最具侵袭性的类型,在保乳手术后复发率最高。筛状和微乳头型钙化灶的特征是点状,大小和形状各异。除了组织学类型外,DCIS的复发还与其在检测时的范围以及保乳手术时是否切除了足够的组织有关。对可疑钙化灶进行活检后应立即进行标本射线摄影,以确认钙化灶已被切除。如果为DCIS选择保乳手术,应采用旨在确定切缘是否无肿瘤的病理技术检查切除的组织段。对于DCIS和具有广泛导管内成分的浸润性癌,建议在放疗前对手术部位进行微焦点放大乳腺摄影,以识别任何残留的肿瘤钙化灶。尽管先进的乳腺钼靶检查在检测钙化灶方面非常敏感,但特异性较低,因此导致大量假阳性乳腺钼靶检查结果和相对较低的真阳性活检率。虽然一些良性钙化灶无法与恶性钙化灶区分开来,但通过仔细分析乳腺钼靶检查结果以寻找提示良性的特征,可以减少对良性病变的活检数量。